Journal of Hepatology
Volume 51, Issue 3 , Pages 483-490 , September 2009

Liver transplantation for glycogen storage disease type Ia

  • Srinevas K. Reddy

      Affiliations

    • Department of Surgery, Duke University Medical Center, Durham, NC, USA
    • ,
  • Stephanie L. Austin

      Affiliations

    • Department of Pediatrics, Duke University Medical Center, 595 LaSalle Street, Durham, NC 27710, USA
    • ,
  • Michele Spencer-Manzon

      Affiliations

    • Department of Pediatrics, Duke University Medical Center, 595 LaSalle Street, Durham, NC 27710, USA
    • ,
  • Dwight D. Koeberl

      Affiliations

    • Department of Pediatrics, Duke University Medical Center, 595 LaSalle Street, Durham, NC 27710, USA
    • ,
  • Bryan M. Clary

      Affiliations

    • Department of Surgery, Duke University Medical Center, Durham, NC, USA
    • ,
  • Dev M. Desai

      Affiliations

    • Department of Surgery, Duke University Medical Center, Durham, NC, USA
    • ,
  • Alastair D. Smith

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC, USA
    • ,
  • Priya S. Kishnani

      Affiliations

    • Department of Pediatrics, Duke University Medical Center, 595 LaSalle Street, Durham, NC 27710, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 919 6811939; fax: +1 919 6848944.

Received 11 February 2009 ,Revised 4 April 2009 ,Accepted 15 May 2009.

References 

  1. Chen YT. Glycogen storage disease. In: 3rd ed..  Scriver CR,  Beaudet AL,  Sly WS,  Valle D editor. The metabolic and molecular bases of inherited disease. vol. 1:New York: McGraw-Hill; 2001;p. 1521–1552
  2. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. Glycogen storage disease type I: diagnosis, management, clinical course, and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr. 2002;161:S20–S34
  3. Smit GPA. The long-term outcome of patients with glycogen storage disease type Ia. Eur J Pediatr. 1993;152(Suppl. 1):S52–S55
  4. Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, et al. Glycogen storage disease in adults. Ann Intern Med. 1994;120:218–226
  5. Bianchi L. Glycogen storage disease I and hepatocellular tumors. Eur J Pediatr. 1993;152:S63–S70
  6. Franco LM, Krishnamurthy V, Bali D, Weinstein DA, Arn P, Clary B, et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis. 2005;288:153–162
  7. Lerut JP, Ciccarelli O, Sempoux C, Danse E, deFlandre J, Horsmans Y, et al. Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation. Transpl Int. 2003;16:879–884
  8. Weinstein DA, Wolfsdorf JI. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type Ia glycogen storage disease. Eur J Pediatr. 2002;161:S35–S39
  9. Coire CI, Qizilbash AH, Castelli MF. Hepatic adenomata in type Ia glycogen storage disease. Arch Pathol Lab Med. 1987;111:166–169
  10. Koeberl DD, Kishnani PS, Chen YT. Glycogen storage disease types I and III: treatment updates. J Inherit Metab Dis. 2007;30:159–164
  11. Faivre L, Houssin D, Valayer J, Brouard J, Hadchouel M, Bernard O. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia. J Inherit Metab Dis. 1999;22:723–732
  12. Lee PJ. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr. 2002;161:S46–S49
  13. Daublin G, Schwahn B, Wendel U. Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence. Eur J Pediatr. 2002;161:S40–S45
  14. Matern D, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr. 1999;158:S43–S48
  15. Liu PP, de Villa VH, Chen YS, Wang CC, Wang SH, Chiang YC, et al. Outcome of living done liver transplantation for glycogen storage disease. Transplant Proc. 2003;35:366–368
  16. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular adenomas I glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr. 1997;24:276–279
  17. Rocco MD, Calevo MG, Taro M, Melis D, Allegri AE, Parenti G. Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease. Mol Gen Metabol. 2008;93:398–402
  18. Labrune P. Glycogen storage disease type I: indications for liver and/or kidney transplantation. Eur J Pediatr. 2002;161:S53–S55
  19. Wiesner RH, McDiarmid SV, Kamath PS, Kremers W, Therneau TM, Kosberg CL, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001;7:567–580
  20. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003;52:134–139
  21. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–96
  22. Reddy SK, Kishnani PS, Sullivan JA, Koeberl DD, Desai DM, Skinner MA, et al. Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol. 2007;47:658–663
  23. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470
  24. Rodriguez-Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant. 2005;5:2244–2247
  25. Davis MK, Weinstein DA. Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure. Pediatr Transplant. 2008;12:137–145
  26. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP, et al. Guidelines for management of glycogen storage disease type I—European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr. 2002;161:S112–S119
  27. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 1996;334:693–700
  28. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for anemia of chronic disease. Blood. 2002;100:3776–3881
  29. Roy CN, Weinstein DA, Andrews NC. The molecular biology of the anemia of chronic disease: a hypothesis. Pediatr Res. 2003;53:507–512
  30. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA. 2001;98:8780–8785
  31. Melis D, Parenti G, Gatti R, Casa RD, Parini R, Riva E, et al. Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type I: a multicentre retrospective study. Clin Endocrinol. 2005;63:19–25
  32. Yiu WH, Pan CJ, Ruef RA, Peng WT, Starost MF, Mansfield BC, et al. Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia. Kidney Int. 2008;73:716–723
  33. Reitsma-Bierens WCC. Renal complications in glycogen storage disease type I. Eur J Pediatr. 1993;152:S60–S62
  34. Baker L, Dahlem S, Goldfarb S, Kern EF, Stanley CA, Egler J, et al. Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int. 1989;35:1345–1350
  35. Chen YT, Coleman RA, Scheinman JI, Kolbeck JC, Sidbury JB. Renal disease in type I glycogen storage disease. NEJM. 1988;318:7–11
  36. Panaro F, Andorno E, Basile G, Morelli N, Bottino G, Fontana I, et al. Simultaneous liver-kidney transplantation for glycogen storage disease type Ia (von Gierke’s disease). Transplant Proc. 2004;36:1483–1484
  37. Lee PJ, Muiesan P, Heaton N. Successful pregnancy after combined renal-hepatic transplantation in glycogen storage disease type Ia. J Inherit Metab Dis. 2004;27:537–538
  38. Belingheri M, Ghio L, Saia A, Menni F, Trespidi L, Ferraresso M, et al. Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines. Liver Transpl. 2007;13:762–764
  39. Desai M, Neuberger N. Chronic liver allograft dysfunction. Transplant Proc. 2009;41:773–776
  40. Iyer SG, Chen CL, Wang CC, Wang SH, Concejero AM, Liu YW, et al. Long-term results of living donor liver transplantation for glycogen storage disorders in children. Liver Transpl. 2007;13:848–852

☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00396-1

doi: 10.1016/j.jhep.2009.05.026

Journal of Hepatology
Volume 51, Issue 3 , Pages 483-490 , September 2009

Article Tools